These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25393480)

  • 21. NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.
    Banerjee NS; Moore DW; Wang HK; Broker TR; Chow LT
    Antiviral Res; 2019 Oct; 170():104559. PubMed ID: 31319090
    [No Abstract]   [Full Text] [Related]  

  • 22. High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.
    White EA; Münger K; Howley PM
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Induction of human oral carcinoma by human papillomavirus 16 E6/E7 and TPA].
    Zhao J; Cao ZY; Sun YT; Liao QP; Du HJ; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):234-6. PubMed ID: 15340565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation.
    Chand V; John R; Jaiswal N; Johar SS; Nag A
    Carcinogenesis; 2014 Aug; 35(8):1830-9. PubMed ID: 24795430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
    Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
    Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
    Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
    Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
    Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
    Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel antimycin analogue antimycin A2c, derived from marine Streptomyces sp., suppresses HeLa cells via disrupting mitochondrial function and depleting HPV oncoproteins E6/E7.
    Zhang W; Che Q; Tan H; Qi X; Li D; Zhu T; Liu M
    Life Sci; 2023 Oct; 330():121998. PubMed ID: 37536615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral oncoproteins and ubiquitination: accessing a cellular toolbox for modifying protein function.
    Thomas M; Banks L
    FEBS J; 2017 Oct; 284(19):3168-3170. PubMed ID: 28972311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
    Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y; McKalip A; Herman B
    J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
    Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets.
    Hoppe-Seyler K; Bossler F; Braun JA; Herrmann AL; Hoppe-Seyler F
    Trends Microbiol; 2018 Feb; 26(2):158-168. PubMed ID: 28823569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
    Mittal S; Banks L
    Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.